Related Experiment Video
Updated: Mar 31, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Immune parameters differentiating active from latent tuberculosis infection in humans
Ji Yeon Lee1, Young Won Jung2, Ina Jeong1
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul 100-799, Republic of Korea.
Active tuberculosis involves lower Th1 cytokine secretion and inflammatory responses compared to latent infection. Plasma analysis revealed distinct lipid mediator profiles, aiding in differential diagnosis and new therapeutic strategies for tuberculosis.
Area of Science:
- Immunology
- Infectious Diseases
- Biochemistry
Background:
- Tuberculosis (TB) is a widespread infectious disease requiring better diagnostic and control methods.
- Differentiating active TB from latent TB infection (LTBI) is crucial for effective management.
- Immune parameters offer potential biomarkers for distinguishing between active and latent TB.
Purpose of the Study:
- To investigate cytokine production profiles of monocytes and CD4(+) T lymphocytes in response to mycobacterial antigens.
- To examine plasma cytokine and lipid mediator levels in active TB patients versus individuals with LTBI.
- To identify immune markers that differentiate active TB from LTBI for improved diagnostics and therapeutics.
Main Methods:
- Analyzed cytokine production from monocytes and CD4(+) T lymphocytes stimulated with mycobacterial antigens.
- Measured plasma concentrations of cytokines and lipid mediators (e.g., lipoxin A4, prostaglandin E2) ex vivo.
- Compared immune profiles between patients with active TB and healthy individuals with LTBI.
Main Results:
- Active TB patients exhibited diminished Th1-type cytokine secretion from CD4(+) T cells compared to LTBI.
- Monocyte inflammatory cytokine secretion induced by IFN-γ was less augmented in active TB than in LTBI.
- Higher plasma lipoxin A4 and a lower prostaglandin E2 to lipoxin A4 ratio were observed in active TB.
Conclusions:
- Specific cytokine and lipid mediator profiles distinguish active TB from LTBI.
- Findings support the development of novel diagnostic tools for differential TB diagnosis.
- Identified immune parameters may inform new therapeutic strategies for active tuberculosis.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

